Zimmer Biomet (ZBH) PT Lowered to $141 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $95.76 -1.75%
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 46 | New: 9
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 46 | New: 9
Join SI Premium – FREE
Oppenheimer analyst Steven Lichtman lowered the price target on Zimmer Biomet (NYSE: ZBH) to $141.00 (from $175.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Zimmer Biomet to Preview the Next Era of Intelligent Orthopedic Surgery at AAHKS 2026
- DoorDash Inc. (DASH) PT Lowered to $250 at Bernstein SocGen Group
- Amazon.com (AMZN) PT Lowered to $340 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
